Takeda: all 1,753 studies

Page 5 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDPCompletedNCT02955355Phase 3Results posted
• Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)CompletedNCT02954848Phase 3Results posted
• Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)CompletedNCT02954458Phase 3Results posted
• A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin LymphomaTerminatedNCT02954406Phase 1Results posted
• Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 StudyCompletedNCT02949362Phase 3Results posted
• Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy ChildrenCompletedNCT02948829Phase 2Results posted
• Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)CompletedNCT02939014Phase 2Results posted
• RIXUBIS Drug Use-Result Survey (Japan)CompletedNCT02937831Results posted
• Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy VolunteersCompletedNCT02932904Phase 4Results posted
• Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or CidofovirCompletedNCT02931539Phase 3Results posted
• A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell TransplantsCompletedNCT02927067Phase 3Results posted
• Ixazomib Rollover StudyCompletedNCT02924272Phase 2Results posted
• TAK-071 Scopolamine-Induced Cognitive Impairment StudyTerminatedNCT02918266Phase 1Results posted
• A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple MyelomaCompletedNCT02917941Phase 2Results posted
• A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in HypoparathyroidismCompletedNCT02910466Phase 4Results posted
• A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy ParticipantsCompletedNCT02906813Phase 1Results posted
• Characterisation and Epidemiology of Breakthrough Cancer Pain in SpainCompletedNCT02899884Results posted
• BAX 802 in CHA With InhibitorsTerminatedNCT02895945Phase 3Results posted
• TAK-438 Bismuth Drug Interaction StudyCompletedNCT02892409Phase 1Results posted
• Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive EsophagitisTerminatedNCT02873702Phase 3Results posted
• Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese PatientsCompletedNCT02873689Phase 3Results posted
• Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)CompletedNCT02865720Phase 3Results posted
• A Retrospective Observational Study to Assess the Impact of Co-morbidities on Treatment Response in Inflammatory Bowel DiseaseCompletedNCT02861118Results posted
• Phase 3 Alogliptin Pediatric StudyCompletedNCT02856113Phase 3Results posted
• Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the BloodCompletedNCT02839902Phase 4Results posted
• Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated DilationCompletedNCT02824432Phase 4Results posted
• Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in BrazilCompletedNCT02822235Results posted
• A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of TAK-828 Escalating Multiple-Doses in Healthy ParticipantsTerminatedNCT02817516Phase 1Results posted
• Cyclobenzaprine HCl Extended Release 15 mg Versus Placebo in Treatment of Cervical and/or Lower Back Pain Due to Muscle Spasms of Local OriginCompletedNCT02814565Phase 3Results posted
• A Food Effect Study of TAK-385 Final FormulationCompletedNCT02792062Phase 1Results posted
• A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With HypertensionCompletedNCT02791438Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic PouchitisCompletedNCT02790138Phase 4Results posted
• A Study of Pevonedistat in Adult East Asian ParticipantsCompletedNCT02782468Phase 1Results posted
• Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With HypoparathyroidismCompletedNCT02781844Phase 1Results posted
• Study of SHP620 (Maribavir) in Healthy AdultsCompletedNCT02775240Phase 1Results posted
• An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes MellitusCompletedNCT02771093Phase 4Results posted
• Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy ParticipantsTerminatedNCT02769065Phase 1Results posted
• Triple Combination Therapy in High Risk Crohn's Disease (CD)CompletedNCT02764762Phase 4Results posted
• FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)CompletedNCT02764489Phase 3Results posted
• An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma ParticipantsTerminatedNCT02761187Results posted
• An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2CompletedNCT02756832Results posted
• International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of KazakhstanCompletedNCT02756819Results posted
• Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy ChildrenCompletedNCT02747927Phase 3Results posted
• Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)CompletedNCT02743949Phase 2Results posted
• Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's DiseaseTerminatedNCT02743806Phase 4Results posted
• Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAECompletedNCT02741596Phase 3Results posted
• ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) ParticipantsCompletedNCT02737501Phase 3Results posted
• An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)CompletedNCT02736409Phase 3Results posted
• Lubiprostone for Chronic Idiopathic Constipation TreatmentCompletedNCT02729909Phase 3Results posted
• Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCTCompletedNCT02728895Phase 1Results posted
• A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial CancerCompletedNCT02725268Phase 2Results posted
• MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell CarcinomaCompletedNCT02724020Phase 2Results posted
• TAK-020 Relative Bioavailability and Food Effect Study in Healthy ParticipantsCompletedNCT02723201Phase 1Results posted
• Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced MelanomaTerminatedNCT02723006Phase 1Results posted
• Stage 1 Study of ARALAST NP and GLASSIA in A1PI DeficiencyTerminatedNCT02722304Phase 3Results posted
• BAX 826 Dose-Escalation Safety StudyCompletedNCT02716194Phase 1Results posted
• Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy ParticipantsCompletedNCT02706834Phase 1Results posted
• A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic TumorsCompletedNCT02699749Phase 1Results posted
• Lubiprostone for Treatment of Chronic Idiopathic ConstipationCompletedNCT02695719Phase 3Results posted
• RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional StudyCompletedNCT02685007Results posted
• Phase 1, TAK-648, Single-Rising Dose StudyCompletedNCT02684396Phase 1Results posted
• Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral NutritionCompletedNCT02682381Phase 3Results posted
• Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term SafetyCompletedNCT02679508Phase 4Results posted
• An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic MedicationsCompletedNCT02678676Results posted
• Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in AdultsCompletedNCT02669121Phase 2Results posted
• The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using ActigraphyCompletedNCT02669082Phase 4Results posted
• Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult SubjectsCompletedNCT02663687Phase 1Results posted
• Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly PopulationCompletedNCT02661490Phase 2Results posted
• A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine FibroidsCompletedNCT02655237Phase 3Results posted
• A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine FibroidsCompletedNCT02655224Phase 3Results posted
• Lubiprostone for the Treatment of Chronic Idiopathic ConstipationCompletedNCT02651155Phase 3Results posted
• Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's DiseaseCompletedNCT02630966Phase 4Results posted
• A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid LeukemiaTerminatedNCT02627677Phase 3Results posted
• A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy ParticipantsCompletedNCT02625259Phase 1Results posted
• A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's DiseaseCompletedNCT02620046Phase 3Results posted
• A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia ACompletedNCT02615691Phase 3Results posted
• Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable SchizophreniaTerminatedNCT02614586Phase 1Results posted
• A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal CancerCompletedNCT02613221Phase 1/2Results posted
• Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative ColitisCompletedNCT02611830Phase 3Results posted
• Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)CompletedNCT02611817Phase 3Results posted
• An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)CompletedNCT02610777Phase 2Results posted
• A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is AchievedCompletedNCT02605837Phase 3Results posted
• Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)CompletedNCT02604407Phase 3Results posted
• Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAECompletedNCT02586805Phase 3Results posted
• BAX 855 PK-guided DosingCompletedNCT02585960Phase 3Results posted
• Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary AngioedemaCompletedNCT02584959Phase 3Results posted
• Study of the Effect of Velaglucerase Alfa (VPRIV®) on Bone-related Pathology in Treatment-naïve Participants With Type 1 Gaucher DiseaseCompletedNCT02574286Phase 4Results posted
• Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's DiseaseCompletedNCT02559713Phase 4Results posted
• Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQviaCompletedNCT02556775Results posted
• Phase 2 Study of TAK-850 in Comparison With Influenza Hemagglutinin (HA) Vaccine in Healthy Adult ParticipantsCompletedNCT02555618Phase 2Results posted
• MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal AdenocarcinomaTerminatedNCT02551055Phase 1Results posted
• A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT02549170Phase 3Results posted
• A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney TransplantTerminatedNCT02547220Phase 3Results posted
• A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese ParticipantsCompletedNCT02541669Phase 1Results posted
• Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian CancerTerminatedNCT02540356Phase 1/2Results posted
• TAK-935 Multiple Rising Dose Study in Healthy ParticipantsCompletedNCT02539134Phase 1Results posted
• Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) StudyCompletedNCT02528786Phase 1Results posted
• GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage StudyCompletedNCT02525861Phase 3Results posted
• A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid TumorsCompletedNCT02525536Phase 1Results posted
• Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in AsiaCompletedNCT02517866Phase 4Results posted

← Takeda overview and focus areas